Innovations in Progress
The journey of every person living with diabetes is personal and unique.
Diabetes management can vary greatly from person to person, creating multiple market segments based on clinical needs and personal preferences. Our goal is to redefine global leadership in insulin delivery with an accessible portfolio of transformational devices, applications and services that reduce the daily burden of living with diabetes.
In support of this strategy, our portfolio of future technologies includes enhancing the features and capabilities of our t:slim X2 and Tandem Mobi insulin pump platforms, including adding a tubeless, extended-wear infusion site option for Tandem Mobi users. Our pipeline also includes a next-generation patch pump that incorporates our Sigi Patch Pump technology, and we anticipate marketing it as the next generation Tandem Mobi. In addition, our development efforts include extended-wear infusion set technology, dual glucose-ketone sensor integration, and algorithm advancement in pursuit of offering fully closed loop technology.
Note: The information on this page discusses products that may not be approved by the FDA. This information is intended for people researching the company, and is updated in conjunction with public announcements about our product innovations. All dates and information are as of November 6, 2025. Tandem Diabetes Care undertakes no obligation to update or review any forward-looking information below based on new information, future events, or other factors.